Cardiovascular Manifestations From Therapeutic RadiationJoshua D. Mitchell, Susan Dent, D. Cehic et al.|JACC CardioOncology|2021Cited by 201
Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapyVanesa Gregorietti, Andrés J. Daniele, Teresa López‐Fernández et al.|Cardio-Oncology|2020Cited by 59
Use of EMPAgliflozin in the prevention of CARDiotoxicity: the EMPACARD – PILOT trialAndrés J. Daniele, Teresa López‐Fernández, Vanesa Gregorietti et al.|Cardio-Oncology|2024Cited by 32
Perspectives on the COVID-19 pandemic impact on cardio-oncology: results from the COVID-19 International Collaborative Network surveyKerry Skurka, Husam Abdel‐Qadir, Eric H. Yang et al.|Cardio-Oncology|2020Cited by 28
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program BuildingDiego Sadler, Sherry‐Ann Brown, Anita Arnold et al.|Current Oncology Reports|2021Cited by 19